The FDA on June 2 launched a generative artificial intelligence tool agencywide to improve internal workflows and staff efficiency.Four things to know.1. The AI tool, Elsa, is currently being used to speed up the review of clinical trial protocols, reduce the time needed to analyze scientific data and identify the agency’s most urgent inspection priorities. […]
